Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287

Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: HORCSCT-9001, NCT01432873

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Dietary intervention FL, NCT00455416

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: 2008-1122, NCT01211561